Downregulation of Nitric Oxide Synthase Activity in Human Platelets by Nitroglycerin and Authentic Nitric Oxide

Journal of Investigative Medicine

Volumn 45, Issue 2, 1997, Pages 69-74

  Chen, Li Ying ^a   Mehta, Jawahar L ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Nitric oxide; Nitroglycerin; Platelet

Indexed keywords

CYCLIC GMP; GLYCERYL TRINITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; ENZYMOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGLYCERIN; PLATELET AGGREGATION;

EID: 0031064455     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nakane M, Schmidt HHHW, Pollock JS, Forstermann U, Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993;316:175-80.
2. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992;267:14519-22.
3. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, DiSilvio M, Wang SC, Nakayma DK, Simmons RL, Snyder SH, Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-5.
4. White KA, Marletta MA, Nitric oxide synthase is a cytochrome P-450 type hemoptotein. Biochemistry 1992;31:6627-31.
5. Stuehr DJ, Ikeda-Saito M. Spectral characterization of brain and macrophage nitric oxide synthases: cytochrome P-450-like heme-proteins that contain a flavin semiquinone radical. J Biol Chem 1992;267:20547-50.
6. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030-3.
7. Bush PA, Gonzalez NE, Ignarro LJ. Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. Biochem Biophys Res Commun 1992;186:308-14.
8. Rogers NE, Ignarro LJ. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide from L-arginine. Biochem Biophys Res Commun 1992;189:242-9.
9. Radomski MW, Palmer RMJ, Moncada S. An L-arginine nitricoxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-7.
10. Radomski MW, Palmer RMJ, Moncada S. Characterization of the L-arginine nitric oxide pathway in human platelets. Br J Pharmacol 1990;101:325-8.
11. Chen LY, Mehta P, Mehta JL. Oxidized-LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance in the effect of oxidized-LDL on platelet function. Circulation 1996;93:1740-6.
12. Mehta JL, Chen LY, Mehta P, Kone BC, Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med 1995;125:370-7.
13. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′,5′ -monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981;57:946-55.
14. Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol 1983;23:653-64.
15. Mehta JL, Mehta P. Comparative effects of nitroprusside and nitroglycerin on platelet aggregation in patients with heart failure. J Cardiovasc Pharmacol 1980;2:25-33.
16. Chen LY, Mehta JL. Lys- and glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation. Thromb Res 1994;74:555-63.
17. Damiani P, Burini G. Fluorometric determination of nitrite. Talanta 1986;33:649-52.
18. Nicolini FA, Wilson AC, Mehta P, Mehta JL. Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J Lab Clin Med 1990;116:147-52.
19. Mehta JL, Chen LY. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets. J Lab Clin Med 1996;127:287-95.
20. Rengasamy A, Johns RA. Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 1993;44:124-8.
21. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993;73:808-12.
22. Sanders KM, Ward SM. Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am J Physiol 1992;262:G379-92.
23. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of corpus caversum in response to nondrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326:90-4.
24. Chen LY, Mehta JL. Antiplatelet effect of nitroglycerin is primarily mediated by glutathione-s-transferases in human plasma. J Am Coll Cardiol 1996;27:302A.
25. Needleman P, Johnson EM Jr. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Therap 1972;184:709-15.
26. Boesgaard S, Aldershvile J, Poulsen HE, Loft S, Anderson ME, Meister A. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ Res 1994;74:115-20.
27. G-monomethyl L-arginine and endothelin-1. J Cardiovasc Pharmacol. In press.
28. Muzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison D. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J Clin Invest 1995;95:187-94.